A brand new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine successfully boosted immunity in mice with metabolic...
A brand new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine successfully boosted immunity in mice with metabolic...